Why Connected Product Strategies Matter for Pharma BD Teams on a Budget

Connected product strategies shape how pharmaceuticals interact with doctors, patients, and clinical researchers through digital tools tied to physical products—think apps that gather patient feedback during trials or smart packaging that tracks drug storage conditions. For global pharma companies with thousands of employees, these strategies can speed up clinical trials, improve patient adherence, and open new revenue streams.

But here’s the catch: many business-development teams at entry-level—especially those juggling tight budgets—find the landscape overwhelming. There’s a temptation to chase every shiny new tech trend or build custom platforms from scratch, risking wasted time and money. Instead, the smartest moves often mean doing less, but smarter.

Below are six practical steps to optimize connected product strategies in pharma that focus on low cost, high impact, and phased rollouts.

1. Start Small with Patient Feedback Tools, Using Free or Low-cost Options

You don’t need a full mobile app or complicated IoT devices to start collecting valuable real-world data. Patient-reported outcomes and feedback are critical in clinical trials to understand drug efficacy and side effects.

Try free tools like Zigpoll, Google Forms, or SurveyMonkey’s free tier to collect structured feedback during early trial phases.

Why it works:

• These platforms require minimal setup and no coding.
• You can send surveys via email or SMS globally.
• Results export easily for analysis in Excel or existing CRM systems.

Gotchas:

• Watch out for GDPR and HIPAA compliance requirements when collecting health data. Keep surveys anonymous where possible or use corporate accounts with security controls.
• Response rates can be low; incentivize participation carefully with tokens or support services.

Example:
A mid-sized pharma team piloted Google Forms for Phase II trials across three countries. They increased patient feedback response rates from 15% to 40% by shortening surveys and sending SMS reminders — all without additional software costs.

2. Identify Core Metrics and Focus on One Connected Feature at a Time

Global corporations often try to build multi-feature platforms at once—tracking drug shipment, patient use, clinician feedback simultaneously. For entry-level BD teams with budget constraints, this diffuses effort and raises costs.

Pick one use case with the highest immediate ROI. For example, tracking medication adherence with smart pill bottles or a companion app.

How to choose:

• Look for the pain point clinical teams complain about most.
• Check what data your existing systems already capture to avoid duplication.
• Estimate the cost and time for each feature using public case studies or vendor pricing.

Example:
A pharma business development group faced a $500K estimate to build a full connected system but found that focusing only on medication adherence tracking saved $400K upfront and improved patient compliance by 12% in one year (source: Pharma Tech Review, 2023).

Edge case:
If your company lacks the infrastructure to handle real-time data, avoid features requiring live monitoring. Instead, focus on batch updates or manual sync that fit existing workflows.

3. Use Open-Source or Modular Platforms Before Building Custom Solutions

Custom software development can blow your budget and timeline, especially with regulatory requirements in pharma. Instead, leverage open-source platforms or modular SaaS products tailored for clinical trials.

Examples include:

• OpenClinica — an open-source electronic data capture platform widely used in pharma.
• REDCap — free to academic and non-profit clinical researchers, offering survey and data capture tools.
• Clinical trial modules from Microsoft Power Platform, providing low-code apps that integrate easily with Office 365.

Implementation tip:
Set aside time for your IT or data teams to evaluate the ease of integrating these tools with your existing systems early on. Even free tools have hidden costs around training and workflow changes.

Limitations:
These platforms may not support all connected device data out-of-the-box. You might need middleware to translate device signals into your system, adding complexity.

4. Roll Out in Phases by Geography or Trial Type to Manage Risk and Costs

Global pharma companies often operate across many countries with diverse regulations and patient populations. Launching a connected product initiative everywhere at once can lead to compliance headaches and ballooning expenses.

Break down the rollout by:

• Country or region
• Specific clinical trial phases (Phase I, II, III)
• Therapeutic area or patient population

This phased approach lets you learn and adjust without overspending.

Example:
One global pharma corporation started connected packaging in Germany and Canada first, where regulators were clear on digital labeling. After six months and a 20% reduction in packaging errors, they expanded to North America and Asia.

Caveat:
This requires tight planning on data standardization and infrastructure so that when you aggregate data later, it’s comparable and compatible.

5. Partner with External Vendors for Shared Risk and Expertise

Rather than building everything in-house, consider partnerships with specialized vendors who offer clinical digital tools on a subscription basis. This reduces upfront investment and taps into vendor experience with regulatory compliance.

Look for vendors who:

• Have pharma-specific use cases (e.g., smart inhalers, trial monitoring apps)
• Offer scalable pricing models (pay per trial or per patient)
• Provide strong data security and privacy certifications

Comparison of typical vendor pricing models:

Example:
A pharma BD team working under a $50K budget leased smart inhaler technology for a Phase II asthma trial. The vendor handled compliance and data management, reducing their workload by 70%, while increasing patient engagement rates by 18%.

6. Use Feedback Tools Like Zigpoll Early to Get Stakeholder Input

Connected product strategies affect many teams: clinical operations, regulatory, IT, marketing, and patients. Gathering input regularly can prevent costly missteps.

Use simple survey tools—like Zigpoll, Typeform, or Microsoft Forms—to get quick feedback from internal stakeholders and trial participants.

Why start here:

• Zero or low cost, easy to set up.
• Identify early resistance or gaps in training.
• Prioritize features or pain points based on real user input.

Pro tip:
Set up recurring pulses during your rollout phases to monitor adoption and capture ideas for improvement.

Limitation:
While useful for qualitative feedback, surveys can’t replace direct user testing or data monitoring, especially for technical features.

Prioritizing Your Moves When Budget Matters Most

If your team has limited resources, start with small, measurable wins that build confidence and gather data to justify further investment:

• Launch patient surveys with free tools to identify the most impactful connected features.
• Focus on one feature that improves clinical trial outcomes or patient adherence.
• Use open-source or SaaS platforms rather than custom builds.
• Roll out regionally or by trial phase to manage complexity and costs.
• Partner with vendors to share risk and reduce upfront spending.
• Continuously gather stakeholder feedback using simple survey tools like Zigpoll to refine your approach.

A 2024 Forrester report showed that pharma teams who followed phased, budget-aware connected product strategies improved trial enrollment efficiency by 23% within the first year. The takeaway? Planning small, thoughtful steps with a focus on collaboration and feedback beats trying to do everything at once.

By being selective, practical, and patient, your business-development team can prove the value of connected products without breaking the bank.